Development of risk factor-based scoring system for detection of hypervirulent

Bloodstream infection Capsular serotype Hypermucoviscosity Hypervirulent Klebsiella pneumoniae Scoring system

Journal

Gut pathogens
ISSN: 1757-4749
Titre abrégé: Gut Pathog
Pays: England
ID NLM: 101474263

Informations de publication

Date de publication:
2020
Historique:
received: 09 05 2020
accepted: 06 07 2020
entrez: 17 7 2020
pubmed: 17 7 2020
medline: 17 7 2020
Statut: epublish

Résumé

Hypervirulent A retrospective cohort study of 222 patients with Simple scoring system was developed for the diagnosis of HVKp infections. The system allows early identification of patients with

Sections du résumé

BACKGROUND BACKGROUND
Hypervirulent
RESULTS RESULTS
A retrospective cohort study of 222 patients with
CONCLUSIONS CONCLUSIONS
Simple scoring system was developed for the diagnosis of HVKp infections. The system allows early identification of patients with

Identifiants

pubmed: 32670415
doi: 10.1186/s13099-020-00374-5
pii: 374
pmc: PMC7346667
doi:

Types de publication

Journal Article

Langues

eng

Pagination

34

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

Clin Microbiol Rev. 2017 Jul;30(3):597-613
pubmed: 28356323
Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):679-689
pubmed: 29238932
Arch Intern Med. 1989 Jun;149(6):1467
pubmed: 2658901
J Clin Microbiol. 2019 Oct 23;57(11):
pubmed: 31434721
Clin Infect Dis. 2006 May 15;42(10):1351-8
pubmed: 16619144
Br J Radiol. 2011 Jun;84(1002):518-25
pubmed: 21081584
J Exp Med. 2004 Mar 1;199(5):697-705
pubmed: 14993253
Virulence. 2017 Oct 3;8(7):1111-1123
pubmed: 28402698
Microbiol Mol Biol Rev. 2016 Jun 15;80(3):629-61
pubmed: 27307579
Clin Infect Dis. 2007 Aug 1;45(3):284-93
pubmed: 17599305
Virulence. 2013 Feb 15;4(2):107-18
pubmed: 23302790
J Clin Pathol. 1976 Apr;29(4):296-304
pubmed: 777042
J Clin Microbiol. 2016 Dec;54(12):3018-3021
pubmed: 27707941
Lancet Infect Dis. 2012 Nov;12(11):881-7
pubmed: 23099082
J Infect Dis. 2006 Mar 1;193(5):645-54
pubmed: 16453259
Radiology. 2011 Jul;260(1):129-38
pubmed: 21460028
Clin Infect Dis. 1999 Nov;29(5):1360-1
pubmed: 10525011
Clin Microbiol Rev. 1998 Oct;11(4):589-603
pubmed: 9767057
Arch Intern Med. 1986 Oct;146(10):1913-6
pubmed: 3532983
Clin Infect Dis. 1999 Dec;29(6):1570-1
pubmed: 10585817

Auteurs

Atsushi Togawa (A)

Department of Medical Oncology, Hematology, and Infectious Diseases, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan, Fukuoka, 8140180 Japan.
Department of Infection Prevention and Control, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan, Fukuoka, 8140180 Japan.

Michinobu Yoshimura (M)

Department of Medical Oncology, Hematology, and Infectious Diseases, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan, Fukuoka, 8140180 Japan.
Present Address: Department of Developmental Medicine, Research Institute, Osaka Women's and Children's Hospital, Osaka, Japan.

Chiemi Tokushige (C)

Department of Laboratory Medicine, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan, Fukuoka, 8140180 Japan.

Akira Matsunaga (A)

Department of Laboratory Medicine, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan, Fukuoka, 8140180 Japan.

Tohru Takata (T)

Department of Medical Oncology, Hematology, and Infectious Diseases, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan, Fukuoka, 8140180 Japan.
Department of Infection Prevention and Control, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan, Fukuoka, 8140180 Japan.

Yasushi Takamatsu (Y)

Department of Medical Oncology, Hematology, and Infectious Diseases, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan, Fukuoka, 8140180 Japan.

Classifications MeSH